Press Releases

Nov 24, 2020
FOSTER CITY, Calif. , Nov. 24, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. , formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases
Additional Formats
Nov 10, 2020
FOSTER CITY, Calif. , Nov. 10, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. , formerly known as SutroVax , a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases
Additional Formats
Sep 09, 2020
FOSTER CITY, Calif. , Sept. 09, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. , formerly known as SutroVax , a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases
Additional Formats
Jun 11, 2020
Foster City, CA, June 11, 2020 (GLOBE NEWSWIRE) -- Vaxcyte, Inc., a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced the
Additional Formats
Jun 03, 2020
Foster City, CA, June 3, 2020 – Vaxcyte, Inc ., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced the
Additional Formats
May 21, 2020
Foster City, CA, May 21, 2020 – SutroVax , Inc., a next-generation vaccine company, today announced that it has changed its name to Vaxcyte, Inc. The new name more accurately reflects the Company’s mission to improve global health by developing superior and novel vaccines designed to prevent or
Additional Formats
Displaying 1 - 10 of 12
Print Page
RSS Feeds
Email Alerts
IR Contact